Company intelligence / Profile preview

Aragen

Hyderabad, Telangana, Indiaaragan.fr ↗

Ownership: Private
Employees: ~2800
Development stage: Commercial

Overview

Aragen provides end-to-end R&D and manufacturing solutions for global life sciences companies. It has supported over 200 cell line development projects with more than 100 entering clinical trials post-IND filing. Several of its developed cell lines are used in marketed products. The company serves over 450 clients worldwide including large pharma, biotech firms, animal health companies, and agrochemical businesses.

Modalities: Monoclonal antibodyBispecific monoclonal antibodyAntibody fragmentFc fusion proteinEnzyme replacement therapyRecombinant proteinSmall molecule
Industry: Drug Discovery Services

Partnerships

Works with several biosimilars companies in India and the EUPartners with leading pharma/biotech globally as contract clients

Beyond the preview

Go deeper on Aragen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aragen.

Explore the full profile